Hexaell Biotech Co., Ltd.
PrivateLast Round
Series B++
Apr 25, 2026
Total Funding Raised
$52.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Hexaell Biotech Co., Ltd. is a biotechnology company that develops therapies for severe liver diseases using cell transdifferentiation technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hexaell Biotech Co., Ltd. Comparables
Compare Hexaell Biotech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| United Therapeutics | 78% | |
| HepaTx Corporation | 57% | |
| Resolution Therapeutics | 56% |
Hexaell Biotech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B++ | Apr 25, 2026 | ||||
| Series B | Feb 11, 2025 | ||||
| Series A | Dec 24, 2018 |
Hexaell Biotech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fuhui Venture Capital | Series B++ |
| Shanghai Healthcare Capital | Series B |
| Shum Yip Capital | Series B++ |
| Zhongshan Cuiheng Group Co., Ltd. | Series B++ |
| Guangdong Technology Financial Group | Series B++ |
| Hyfinity Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 25, 2026
$14M round with participation from Shum Yip Capital and Fuho Capital.
- Feb 11, 2025
$31M round led by Shanghai Biomedical Industrial Equity Investment Fund
Hexaell Biotech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hexaell Biotech Co., Ltd.'s valuation, stock price, and market status.
Is Hexaell Biotech Co., Ltd. a public or private company?
Hexaell Biotech Co., Ltd. is a private company.
What is the current stock price of Hexaell Biotech Co., Ltd.?
Hexaell Biotech Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Hexaell Biotech Co., Ltd. worth (valuation)?
Valuation information for Hexaell Biotech Co., Ltd. is not publicly available.
Can I buy Hexaell Biotech Co., Ltd. stock?
Hexaell Biotech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hexaell Biotech Co., Ltd.'s last funding round?
Hexaell Biotech Co., Ltd.'s most recent funding round was Series B++ on April 25, 2026.
Who are the main investors in Hexaell Biotech Co., Ltd.?
Key investors in Hexaell Biotech Co., Ltd. include Shanghai Healthcare Capital, Hyfinity Investments.
Will Hexaell Biotech Co., Ltd. IPO soon?
No public IPO plans have been announced for Hexaell Biotech Co., Ltd..
How can I track Hexaell Biotech Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hexaell Biotech Co., Ltd.'s secondary market activity and sign up for updates.